IX Biopharma News

IX Biopharma: General Announcement-Press Release - Launch of Sublingual Dexmedetomidine Programme

Aug 29, 2022 07:33

IX Biopharma: Financial Statements and Related Announcement-Full Yearly Results

Aug 23, 2022 06:05

IX Biopharma: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Changes in Interest by Substantial Shareholder - Eddy Lee Yip Hang

Jul 26, 2022 17:19

IX Biopharma: Placements-PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES - ALLOTMENT AND ISSUE OF SUBSCRIPTION SHARES

Jul 21, 2022 18:45

IX Biopharma: Placements-PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES - RECEIPT OF LISTING AND QUOTATION NOTICE

Jul 19, 2022 21:29

IX Biopharma: General Announcement-DRUG DEVELOPMENT UPDATES FOR WAFERMINE AND WAFESIL

Jul 19, 2022 07:28

IX Biopharma: Change - Announcement of Cessation-Cessation of Director of Corporate Affairs & General Manager - Yee Chia Hsing

Jul 15, 2022 17:21

IX Biopharma: Placements-PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES

Jul 12, 2022 19:23

IX Biopharma: REPL-Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla

Jul 7, 2022 19:24

IX Biopharma: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla

Jul 6, 2022 17:22

IX Biopharma: Request for Lifting of Trading Halt-Request for Lifting of Trading Halt

Feb 11, 2022 13:14

IX Biopharma: General Announcement-Request for Lifting of Trading Halt - Sponsor's Statement

Feb 11, 2022 13:12

IX Biopharma: Request for Lifting of Trading Halt-Request for Lifting Of Trading Halt

Feb 11, 2022 13:11

IX Biopharma: Request for Trading Halt-Request for Trading Halt

Feb 11, 2022 12:55

IX Biopharma: General Announcement-Press Release-iX Biopharma Records 1H22 Net Profit of S$3.66M

Feb 11, 2022 12:32

IX Biopharma: Financial Statements and Related Announcement-Half Yearly Results

Feb 11, 2022 12:31

IX Biopharma: General Announcement-Change of Secretaries

Feb 4, 2022 17:27

IX Biopharma: General Announcement-APPOINTMENT OF NON-EXECUTIVE INDEPENDENT DIRECTOR & CHANGE IN COMPOSITION OF BOARD & ITS COMMITTEES

Jan 28, 2022 17:40

IX Biopharma: Change - Announcement of Appointment-APPOINTMENT OF NON-EXECUTIVE INDEPENDENT DIRECTOR

Jan 28, 2022 17:25

IX Biopharma: General Announcement-Phillip Securities Presentation - January 2022

Jan 20, 2022 17:42